All Asthma articles
-
NICE guidelineNICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
-
Supplement
The re-usable Respimat® Soft Mist inhaler
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines for Nurses.
View prescribing information
PC-GB-103143 November 2020 -
Supplement
The re-usable Respimat® Soft Mist inhaler
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View prescribing information
PC-GB-103141 November 2020 -
Prescribing summary card
DuoResp® Spiromax® (budesonide/formoterol)
This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Click here for prescribing information and adverse event reporting.
DUOR-GB-00021
Date of preparation: August 2020 -
Independent professional body guideline
AWMSG asthma guideline
Core principles of asthma management, inhaler selection and use, and referral guidance, from the All Wales Medicines Strategy Group
-
Working party guideline/algorithm
Identifying and managing allergic rhinitis in the asthma population
This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.
-
Independent professional body guideline
BTS/SIGN asthma in pregnancy guideline
This summary focuses on recommendations for the management of asthma in pregnant women, including during labour, and recommendations for breastfeeding mothers
-
Information
GINA ASTHMA STRATEGY 2020
Asthma affects an estimated 300 million individuals worldwide, and still imposes an unacceptable burden on healthcare systems, society through loss of productivity in the workplace, and, especially for paediatric asthma, disruption to the family. Asthma affects all age groups and contributes to many deaths worldwide. The Global Initiative for ...
-
Working party guideline/algorithm
Inhaler choice guideline
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.
-
Independent professional body guideline
GINA strategy 2020: assessing patients with asthma
This Guidelines summary outlines recommendations for assessing patients with asthma. Please refer to the full report for the complete set of recommendations.
-
Independent professional body guideline
GINA strategy 2020: asthma–COPD overlap
This Guidelines summary outlines recommendations for the diagnosis and initial treatment of adults with features of asthma, chronic obstructive pulmonary disease (COPD), or both.
-
Independent professional body guideline
GINA strategy 2020: management of asthma
This Guidelines summary outlines recommendations for the management of asthma in adults, adolescents, and children aged six to 11.
-
Independent professional body guideline
GINA strategy 2020: diagnosis of asthma
This Guidelines summary outlines recommendations for making the diagnosis of asthma in adults and children over five years of age. Please refer to the full report for the complete set of recommendations.
-
Independent professional body guideline
BTS/SIGN management of difficult asthma guideline
This brief summary of BTS/SIGN guidance on the assessment and management of difficult asthma includes information on contributory factors and monitoring.
-
Video
Dr Kevin Gruffydd–Jones Q&A on asthma
In this video, taken at Guidelines Live 2019, Dr Kevin Gruffydd–Jones answers questions on recent asthma guidelines updates, significant differences between the guideline updates, what is on the horizon for asthma guidelines, and his key take-home messages.
-
Video
Dr Mark Levy Q&A on difficult-to-treat and severe asthma
In this video, taken at Guidelines Live 2019, Dr Mark Levy answers questions on difficult-to-treat and severe asthma, the guidance that is available, and his key take-home messages
-
Independent professional body guideline
SIGN and BTS management of asthma in adults guideline
A concise summary of the 2019 BTS/SIGN guidance on the management of asthma in adults. Features a diagnosis and pharmacological management algorithm.
-
-
Independent professional body guideline
BTS/SIGN occupational asthma guideline
A brief summary of BTS/SIGN guidance on occupational asthma and rhinitis, including a management algorithm for primary care and a list of high risk work.
-
Independent professional body guideline
BTS/SIGN asthma in adolescents guideline
A clear summary of BTS/SIGN guidance on the assessment, diagnosis, and management of asthma in adolescents, including patient education and self-management.
